Back
Calamos Strategic Total Return Fund Vs. BioNTech SE Industry Stock Comparison
Buy
63
CSQ
Calamos Strategic Total Return Fund
Last Price:
16.84
Seasonality Move:
0.91%
Sell
29
BNTX
BioNTech SE
Last Price:
84.38
Seasonality Move:
13.76%
Buy
63
Calamos Strategic Total Return Fund (CSQ)
is a Buy
Is Calamos Strategic Total Return Fund a Buy, Sell or Hold?
- The current Calamos Strategic Total Return Fund [CSQ] share price is $16.77. The Score for CSQ is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- CSQ is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
29
BioNTech SE (BNTX)
is a Sell
Is BioNTech SE a Buy, Sell or Hold?
- The current BioNTech SE [BNTX] share price is $86.52. The Score for BNTX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- BNTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CSQ Stock Price Chart
What is Calamos Strategic Total Return Fund's stock price today?
-
The Calamos Strategic Total Return Fund share price today is $16.77
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CSQ is experiencing selling pressure, which indicates risk of future bearish movement.
BNTX Stock Price Chart
What is BioNTech SE's stock price today?
-
The BioNTech SE share price today is $86.52
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BNTX is experiencing slight buying pressure.
CSQ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 61.81 | Buy |
| Chaikin Money Flow: | -149912 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.29 - 16.77) | Buy |
| Bollinger Bands (100): | (15.69 - 16.45) | Buy |
BNTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.06 | Sell |
| Relative Strength Index (14 RSI): | 37.29 | Sell |
| Chaikin Money Flow: | 354895 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (89.63 - 100.89) | Sell |
| Bollinger Bands (100): | (88.37 - 96.23) | Sell |
CSQ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.82 | Sell |
| 20-day SMA: | 16.57 | Buy |
| 50-day SMA: | 16.17 | Buy |
| 200-day SMA: | 15.17 | Buy |
| 8-day EMA: | 16.79 | Sell |
| 20-day EMA: | 16.62 | Buy |
| 50-day EMA: | 16.33 | Buy |
| 200-day EMA: | 15.5 | Buy |
BNTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 89.72 | Sell |
| 20-day SMA: | 95.26 | Sell |
| 50-day SMA: | 92.4 | Sell |
| 200-day SMA: | 97.5 | Sell |
| 8-day EMA: | 89.21 | Sell |
| 20-day EMA: | 92.66 | Sell |
| 50-day EMA: | 93.24 | Sell |
| 200-day EMA: | 99.08 | Sell |
Calamos Strategic Total Return Fund Earnings Growth & CSQ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
BioNTech SE Earnings Growth & BNTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.82 per share, a decrease next quarter of $0.67 per share, a decrease this year of $6.67 per share, and a decrease next year of $0.60 per share.
Calamos Strategic Total Return Fund Technical Analysis
| Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BioNTech SE Technical Analysis
| Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||